BIGLARI HOLDINGS INC-A (BH.A) Fundamental Analysis & Valuation

NYSE:BH.A • US08986R4083

Current stock price

1662 USD
-43.64 (-2.56%)
Last:

This BH.A fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BH.A Profitability Analysis

1.1 Basic Checks

  • BH.A had negative earnings in the past year.
  • In the past year BH.A had a positive cash flow from operations.
  • In multiple years BH.A reported negative net income over the last 5 years.
  • In the past 5 years BH.A always reported a positive cash flow from operatings.
BH.A Yearly Net Income VS EBIT VS OCF VS FCFBH.A Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

1.2 Ratios

  • With a Return On Assets value of -3.66%, BH.A is not doing good in the industry: 74.60% of the companies in the same industry are doing better.
  • BH.A has a Return On Equity (-7.16%) which is comparable to the rest of the industry.
  • BH.A has a worse Return On Invested Capital (1.98%) than 71.43% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BH.A is significantly below the industry average of 10.60%.
Industry RankSector Rank
ROA -3.66%
ROE -7.16%
ROIC 1.98%
ROA(3y)0.79%
ROA(5y)0.49%
ROE(3y)0.45%
ROE(5y)0.3%
ROIC(3y)2.87%
ROIC(5y)3.54%
BH.A Yearly ROA, ROE, ROICBH.A Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

  • BH.A has a worse Operating Margin (5.51%) than 61.11% of its industry peers.
  • BH.A's Operating Margin has declined in the last couple of years.
  • BH.A has a worse Gross Margin (37.80%) than 69.05% of its industry peers.
  • In the last couple of years the Gross Margin of BH.A has grown nicely.
Industry RankSector Rank
OM 5.51%
PM (TTM) N/A
GM 37.8%
OM growth 3Y-23.69%
OM growth 5Y-3.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.06%
GM growth 5Y3.66%
BH.A Yearly Profit, Operating, Gross MarginsBH.A Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BH.A Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BH.A is destroying value.
  • BH.A has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BH.A has been reduced compared to 5 years ago.
  • BH.A has a worse debt/assets ratio than last year.
BH.A Yearly Shares OutstandingBH.A Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M
BH.A Yearly Total Debt VS Total AssetsBH.A Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 6.17 indicates that BH.A is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of BH.A (6.17) is better than 90.48% of its industry peers.
  • BH.A has a debt to FCF ratio of 4.13. This is a neutral value as BH.A would need 4.13 years to pay back of all of its debts.
  • BH.A's Debt to FCF ratio of 4.13 is fine compared to the rest of the industry. BH.A outperforms 76.19% of its industry peers.
  • A Debt/Equity ratio of 0.53 indicates that BH.A is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.53, BH.A is in the better half of the industry, outperforming 63.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 4.13
Altman-Z 6.17
ROIC/WACC0.23
WACC8.64%
BH.A Yearly LT Debt VS Equity VS FCFBH.A Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • BH.A has a Current Ratio of 2.43. This indicates that BH.A is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of BH.A (2.43) is better than 87.30% of its industry peers.
  • BH.A has a Quick Ratio of 2.40. This indicates that BH.A is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of BH.A (2.40) is better than 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.4
BH.A Yearly Current Assets VS Current LiabilitesBH.A Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BH.A Growth Analysis

3.1 Past

  • BH.A shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -975.27%.
  • BH.A shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.15%.
  • The Revenue has been decreasing by -1.84% on average over the past years.
EPS 1Y (TTM)-975.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-414.41%
Revenue 1Y (TTM)9.15%
Revenue growth 3Y2.39%
Revenue growth 5Y-1.84%
Sales Q2Q%9.61%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH.A Yearly Revenue VS EstimatesBH.A Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
BH.A Yearly EPS VS EstimatesBH.A Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

1

4. BH.A Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BH.A. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BH.A Price Earnings VS Forward Price EarningsBH.A Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BH.A indicates a rather expensive valuation: BH.A more expensive than 81.75% of the companies listed in the same industry.
  • BH.A's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 49.47
EV/EBITDA 60.7
BH.A Per share dataBH.A EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BH.A Dividend Analysis

5.1 Amount

  • BH.A does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BH.A Fundamentals: All Metrics, Ratios and Statistics

BIGLARI HOLDINGS INC-A

NYSE:BH.A (3/20/2026, 12:16:34 PM)

1662

-43.64 (-2.56%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-02
Earnings (Next)05-07
Inst Owners94.26%
Inst Owner Change0.81%
Ins Owners0.4%
Ins Owner ChangeN/A
Market Cap3.79B
Revenue(TTM)395.26M
Net Income(TTM)-37.49M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.59
P/FCF 49.47
P/OCF 35.43
P/B 7.24
P/tB 8.47
EV/EBITDA 60.7
EPS(TTM)-72.75
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)33.6
FCFY2.02%
OCF(TTM)46.91
OCFY2.82%
SpS173.36
BVpS229.57
TBVpS196.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.66%
ROE -7.16%
ROCE 2.51%
ROIC 1.98%
ROICexc 3.24%
ROICexgc 3.78%
OM 5.51%
PM (TTM) N/A
GM 37.8%
FCFM 19.38%
ROA(3y)0.79%
ROA(5y)0.49%
ROE(3y)0.45%
ROE(5y)0.3%
ROIC(3y)2.87%
ROIC(5y)3.54%
ROICexc(3y)3.74%
ROICexc(5y)4.4%
ROICexgc(3y)4.29%
ROICexgc(5y)5.05%
ROCE(3y)3.69%
ROCE(5y)4.51%
ROICexgc growth 3Y-18.85%
ROICexgc growth 5Y-2.07%
ROICexc growth 3Y-19.26%
ROICexc growth 5Y-2.43%
OM growth 3Y-23.69%
OM growth 5Y-3.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.06%
GM growth 5Y3.66%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 4.13
Debt/EBITDA 4.44
Cap/Depr 74.43%
Cap/Sales 7.68%
Interest Coverage 250
Cash Conversion 170.92%
Profit Quality N/A
Current Ratio 2.43
Quick Ratio 2.4
Altman-Z 6.17
F-Score3
WACC8.64%
ROIC/WACC0.23
Cap/Depr(3y)70.42%
Cap/Depr(5y)101.43%
Cap/Sales(3y)7.51%
Cap/Sales(5y)9.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-975.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-414.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.15%
Revenue growth 3Y2.39%
Revenue growth 5Y-1.84%
Sales Q2Q%9.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.97%
EBIT growth 3Y-21.87%
EBIT growth 5Y-5.09%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y301.79%
FCF growth 3Y-7.91%
FCF growth 5Y-4.59%
OCF growth 1Y115.38%
OCF growth 3Y-5.76%
OCF growth 5Y-1.88%

BIGLARI HOLDINGS INC-A / BH.A Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BIGLARI HOLDINGS INC-A (BH.A) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BH.A.


What is the valuation status for BH.A stock?

ChartMill assigns a valuation rating of 1 / 10 to BIGLARI HOLDINGS INC-A (BH.A). This can be considered as Overvalued.


How profitable is BIGLARI HOLDINGS INC-A (BH.A) stock?

BIGLARI HOLDINGS INC-A (BH.A) has a profitability rating of 2 / 10.


What is the financial health of BIGLARI HOLDINGS INC-A (BH.A) stock?

The financial health rating of BIGLARI HOLDINGS INC-A (BH.A) is 7 / 10.